• P&G Health, makers of Neurobion, embark on an effort to help people 'Put Life Back in Their Hands' for an improved quality of life.
• Launched on World Diabetes Day across 18 countries, the campaign raises awareness on Peripheral Neuropathy in diabetes, and the importance of early identification and timely treatment.

With Diabetes Mellitus being the leading cause^[2] of Peripheral Neuropathy (PN), the increasing prevalence of PN is closely linked to the rise in the number of diabetic patients. PN including Diabetic Peripheral Neuropathy (DPN) is the result of damage to the nerves impacting quality of life of people as they are not able to go about their daily lives as comfortably. Symptoms of peripheral neuropathy include numbness, tingling, prickling, and burning sensations in the hands and feet. Besides diabetes mellitus, B vitamins deficiencies and aging are other high-risk factors leading to peripheral nerve damage.

FAST FACTS:

• In 2021, there were 393 million diabetic patients^[3] in the Asia Pacific, Middle East, and African regions projected to rise to 603 million by 2045^[3]. 
• With ~50%^[1] of diabetic patients indicating that they suffer from Peripheral Neuropathy, there will be an exponential growth in the number of patients in these regions with PN.
• Less than one-third of physicians recognize signs of DPN. Undiagnosed cases contributing greatly to the high rates of morbidity and mortality of diabetes^[3]. Up to 50 % of patients are asymptomatic and therefore often remain undiagnosed and are at risk of insensate injury^[4].
• If not diagnosed and treated early, DPN can develop into neuropathic pain which has a tremendous impact on the quality of life. 
• To decrease the risk of DPN, regular screening, early detection and patient education are crucial for optimal treatment outcomes.